1.
Wu K, van Wieringen W, Vellenga E, Zweegman S, Lokhorst H, Sonneveld P. Analysis of the efficacy and toxicity of bortezomib for treatment of relapsed or refractory multiple myeloma in community practice. Haematologica 2005; 90(7):996-997.